Paratek Pharmaceuticals - 3 Year Dividend History | PRTK
Historical dividend payout and yield for Paratek Pharmaceuticals (PRTK) since 2016. The current TTM dividend payout for Paratek Pharmaceuticals (PRTK) as of December 13, 2019 is $0.00. The current dividend yield for Paratek Pharmaceuticals as of December 13, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutics that treat infectious disease agents. The Company's lead product candidate, omadacycline, is a tetracycline-derived antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. Its second product candidate, WC 3035 is a tetracycline-derived compound designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals, Inc., formerly known as Transcept Pharmaceuticals, Inc., is based in United States.